Syndax Pharmaceuticals SNDX Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Syndax Pharmaceuticals's change in AR?
- Syndax Pharmaceuticals (SNDX) reported change in AR of -$120K in Q1 2026.
- How has Syndax Pharmaceuticals's change in AR changed year-over-year?
- Syndax Pharmaceuticals's change in AR decreased by 101.5% year-over-year, from $8.12M to -$120K.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.